Total | 22 weeks | 23 weeks | 24 weeks | |
n=3318 | n=454 | n=1230 | n=1634 | |
Death | 0.70 (0.59 to 0.83) | 0.55 (0.34 to 0.91) | 0.58 (0.43 to 0.77) | 0.71 (0.53 to 0.94) |
Death or cerebral palsy | 0.65 (0.55 to 0.76) | 0.49 (0.30 to 0.81) | 0.49 (0.37 to 0.65) | 0.72 (0.55 to 0.93) |
Death or visual impairments | 0.59 (0.50 to 0.69) | 0.59 (0.36 to 0.97) | 0.47 (0.36 to 0.62) | 0.55 (0.42 to 0.71) |
Death or hearing impairments | 0.69 (0.58 to 0.81) | 0.55 (0.34 to 0.90) | 0.57 (0.43 to 0.76) | 0.68 (0.52 to 0.90) |
Death or DQ of KSPD<70 | 0.91 (0.78 to 1.06) | 0.94 (0.54 to 1.63) | 0.71 (0.55 to 0.94) | 0.94 (0.75 to 1.19) |
Death or NDI | 0.83 (0.71 to 0.97) | 0.99 (0.57 to 1.72) | 0.64 (0.49 to 0.84) | 0.86 (0.68 to 1.07) |
Values are ORs (95% CIs) after adjustments by a multivariate logistic regression with the multiple imputation method. Adjusted variables were the centre, gender, multiple gestation, maternal age, caesarean delivery, antenatal steroid use, pregnancy-related hypertension, clinical chorioamnionitis, life-threatening congenital anomalies and birth weight.
DQ, developmental quotient; KSPD, Kyoto Scale of Psychological Development; NDI, neurodevelopmental impairment.